Cambridge Isotope Laboratories, Inc. Announces Expansion of 13C Capacity at Ohio Plant

"The expansion was initiated in response to the strong and growing demand by our customers for 13C and 13C urea," says Mike Steiger, VP of Project Engineering and Execution. "There is an increasing need for isotopes for medical investigations and 13C plays an important role." The 13C isotope is known to be used in a variety of applications for environmental analysis, medical research, and medical diagnostics. Medical diagnosis-based CO2 breath tests, such as 13C urea (used to detect Helicobacter pylori bacterial infection) and 13C methacetin for liver disease, can aid in the prevention of invasive procedures.

"The expansion was initiated in response to the strong and growing demand by our customers for ¹³C and ¹³C urea," says Mike Steiger, VP of Project Engineering and Execution. "There is an increasing need for isotopes for medical investigations and ¹³C plays an important role." The ¹³C isotope is known to be used in a variety of applications for environmental analysis, medical research, and medical diagnostics. Medical diagnosis-based CO₂ breath tests, such as ¹³C urea (used to detect Helicobacter pylori bacterial infection) and ¹³C methacetin for liver disease, can aid in the prevention of invasive procedures.

¹³C is a nonradioactive (stable) element which makes up approximately 1% of all carbon atoms in nature. At the CIS plant in Ohio, natural carbon monoxide (containing ~1% ¹³C) is cryogenically liquefied and then distilled through several long specially designed distillation columns, which make it one of the world's longest distillation systems of any kind. CIL has continuously demonstrated its expertise in the area of cryogenic distillation and maintain our place as the world's leading producer of ¹³C isotope. The end-product of this process is carbon monoxide that is greater than 99% ¹³C, which is then used to manufacture any one of the thousands of isotope-labeled products offered by CIL.

About Cambridge Isotope Laboratories, Inc.  

CIL is the world's largest manufacturer and global supplier of stable isotopes and stable isotope-labeled compounds used in research, environmental, neonatal, pharmaceutical, medical diagnostic, OLED, and industrial markets. CIL is an operating business owned by Otsuka Pharmaceuticals. The CIL business consists of two facilities in the Boston, MA, area; a large isotope-enrichment production plant in Xenia, OH; CIL China; CIL Canada; ABX in Dresden, Germany; and Eurisotop in Saclay, France.  

For more information on CIL, visit isotope.com.

Related Images

image1.jpg